← All diseases
Cancer
Bile duct cancer
Would you like to receive a message when there is new research on cholangiocarcinoma? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a one-sentence summary explaining what was studied appears above each publication — and you'll be notified as soon as new research on Cholangiocarcinoma is published. View what Premium costs.
Publications and studies (2068)
- Microbial Composition Study in Cholangiocarcinoma: Stage-Specific Diversity Analysis in Bile and Tumor Microbiome. (2026/07/01) ♡
- Betulinic Acid Extracted from Guava (Psidium guajava L.) Leaves Inhibits Human Cholangiocarcinoma Cell Metastasis by Activating E-cadherin and Inhibiting MMP-9 and VEGF. (2026/07/01) ♡
- Study of the Role of Circulating Cell-Free DNA in the Diagnosis of Cholangiocarcinoma. (2026/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Endobiliary radiofrequency ablation for malignant biliary obstruction: clinical benefits, limitations, and future directions. (2026/07/01) ♡
- Novel Immunotherapy Agents in Early-Phase Trials for Head and Neck Cancer. (2026/07/01) ♡
- Determinants of preventive behaviors against liver fluke and cholangiocarcinoma in Laos: A TPB-based cross-sectional study. (2026/06/30) ♡
- The Impact of "The Magic Glasses Opisthorchiasis" on Schoolchildren's Knowledge, Attitudes and Practices Surrounding Opisthorchis viverrini in the Lower Mekong Basin, a Cluster-Randomised Controlled Trial. (2026/06/24) ♡
- IGF2BP1-Mediated m⁶A Modification Stabilizes HMGA2 mRNA to Promote Intrahepatic Cholangiocarcinoma Progression. (2026/06/24) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Artificial intelligence-guided analysis of the tumor microenvironment predicts response to pembrolizumab in rare tumors. (2026/06/24) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Gut Microbiota Modulation as a Therapeutic Strategy for Insomnia: A Systematic Review of Nutritional and Botanical Interventions. (2026/06/23) ♡
- Clinical vulnerability to chemotherapy in cholangiocarcinoma: impact of nutritional status, frailty, and systemic inflammation. (2026/06/17) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Biomarker study of pembrolizumab in patients with advanced rare cancers. (2026/06/16) ♡
- Galectin 3 expression in gastrointestinal tumors identified through comprehensive bioinformatic mapping. (2026/06/10) ♡
- Multiomics- and artificial intelligence-powered research platforms for enhancing understanding and prediction of the cholangiocarcinoma patient journey. (2026/06/09) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Systemic therapy of biliary tract cancer: The road to personalised strategies. (2026/06/08) ♡
- Visceral adipose tissue-to-blood pool standardized uptake ratio by (18)F-FDG-PET/CT predicts malnutrition and poor prognosis in patients with extrahepatic cholangiocarcinoma. (2026/06/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Prognostic models for intrahepatic cholangiocarcinoma after resection: A systematic review and meta-analysis. (2026/06/01) ♡
- Artificially Sweetened and Sugar-Sweetened Beverage Intake and Risk of Liver Cancer. (2026/06/01) ♡
- A multicenter study identifies an immune inflammatory and nutritional prognostic signature in intrahepatic cholangiocarcinoma. (2026/05/16) ♡
- A Time-Dependent Prognostic Score (Helsinki Primary Sclerosing Cholangitis Score) to Predict Disease Outcomes in Primary Sclerosing Cholangitis. (2026/05/12) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Preoperative biliary drainage in perihilar cholangiocarcinoma: retrospective multicentre analysis. (2026/05/12) ♡
- Clonorchis sinensis excretory secretory products promote hepatic fibrosis through stimulating biliary epithelium to secrete IL-17A. (2026/05/05) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Molecular profiling and matched targeted treatment in cholangiocarcinoma: Results from the Italian dataset (ANITA). (2026/05/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Correct diagnosis of patients with fibrolamellar carcinoma: A Dutch nationwide study. (2026/05/01) ♡
- Robotic Hepatic Artery Infusion (HAI) Port Placement for Liver-Directed Intra-Arterial Chemotherapy: Initial Experience from a Tertiary Care Indian Cancer Center. (2026/05/01) ♡
- Atypical Ductular Reactions Are a Distinct Regenerative Phenomenon in Patients With Hepatocellular Carcinoma (HCC) After Transarterial Chemoembolization. (2026/05/01) ♡
- End-of-life care patterns for cholangiocarcinoma in the United States: A 26-year analysis of home and hospice deaths by demographic, regional, and urbanization factors. (2026/05/01) ♡
- Accurate detection of cholangiocarcinoma in primary sclerosing cholangitis using DNA methylation biomarkers in bile and plasma. (2026/04/29) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Nutritional-Inflammatory Recovery After Metal versus Plastic Biliary Stenting in Elderly Cholangiocarcinoma: A Prospective Observational Cohort Study. (2026/04/14) ♡
- Outcomes of patients with or without DNA repair pathway alterations: the MD Anderson IMPACT2 study. (2026/04/10) ♡
- Arachidonic Acid Metabolism in PMN-MDSCs Suppresses Antitumor Capacity of T cells in KRAS-Mutant Cholangiocarcinoma. (2026/04/08) ♡
- Effectiveness of transarterial drug-loaded microsphere chemoembolization against cholangiocarcinoma combined with obstructive jaundice. (2026/04/06) ♡
- Perspectives of Early to Mid-Career health professionals: Future public health challenges and opportunities in the Asia-Pacific region. (2026/04/02) ♡
- Two stable gut microbiome guilds predict liver tumor class and treatment responses. (2026/04/02) ♡
- Time-dependent diffusion-weighted MRI discriminates hepatocellular carcinoma from intrahepatic cholangiocarcinoma: A prospective animal model study. (2026/04/01) ♡
- Real-world impact of the management of advanced perihilar and extrahepatic cholangiocarcinoma on prognosis. (2026/04/01) ♡
- Chemical composition and anticancer potential of water extracts derived from ground powder of Thai germinated brown rice (Oryza sativa L.). (2026/04/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Higher consumption of ultra-processed foods and long-term risk of metabolic dysfunction-associated steatotic liver disease and primary liver cancer: A meta-analysis of preliminary evidence. (2026/04/01) ♡
- Endoscopic management of biliary stricture in primary sclerosing cholangitis. (2026/03/25) ♡
- Severe nail toxicity induced by FGFR inhibitor in FGFR2-rearranged cholangiocarcinoma. (2026/03/14) ♡
- Autoimmune cholangiopathy presenting as a mimicker of hilar cholangiocarcinoma. (2026/03/12) ♡
- Telemedicine as a gateway to early-phase oncology trials: lessons from 14 000 patients and future directions for global access and equity. (2026/03/09) ♡
- Combined Model of Inflammatory-Nutritional Indicators and Tumor Markers for Predicting Prognosis in Patients with Distal Cholangiocarcinoma: A Retrospective Cohort Study. (2026/03/05) ♡
- High sensitivity of biliary brush cytology in patients with suspected perihilar or intrahepatic cholangiocarcinoma: a prospective cohort comparison with historical controls. (2026/03/01) ♡
- Surveillance imaging detects hepatocellular adenomas and carcinomas in individuals with Fontan circulation. (2026/03/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Concordance analysis of DNA and RNA profiling: The MD Anderson IMPACT2 study in precision oncology. (2026/02/24) ♡
- A compass in the challenge: the CALLY index as a prognostic biomarker in advanced cholangiocarcinoma treated with chemoimmunotherapy: a retrospective propensity score-matched cohort study. (2026/02/24) ♡
- Comprehensive identification of microbial and metabolomic factors impacting ICC recurrence. (2026/02/12) ♡
- Stage-Dependent Metabolic Responses to Oral Nutritional Supplementation in Cancer Cachexia: A Single-Arm Pilot Study. (2026/02/11) ♡
- Understanding hepatopancreatobiliary cancer risks in a population-based primary sclerosing cholangitis-inflammatory bowel disease cohort. (2026/02/04) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.